|
Market Closed -
Borsa Italiana
16:45:00 06/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 1.080 EUR | -0.46% |
|
+2.86% | -26.53% |
| 09-27 | Laboratorio Farmaceutico Erfo S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 08-31 | Milan in the pink at the open, oil stocks lead the MIB | AN |
Company Valuation: Laboratorio Farmaceutico Erfo S.p.A.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 18.27 | 11.79 | 10.8 | 12.53 | 9.194 | - | - |
| Change | - | -35.47% | -8.4% | 16.03% | -26.63% | - | - |
| Enterprise Value (EV) 1 | 17.27 | 10.07 | 8.726 | 12.03 | 7.394 | 6.794 | 5.994 |
| Change | - | -41.73% | -13.31% | 37.9% | -38.55% | -8.11% | -11.78% |
| P/E | - | - | - | - | 8.31x | 9.82x | 7.71x |
| PBR | - | - | - | - | - | - | - |
| PEG | - | - | - | - | - | -0.6x | 0.3x |
| Capitalization / Revenue | 3.63x | 1.88x | 1.7x | 1.25x | 0.91x | 0.84x | 0.79x |
| EV / Revenue | 3.43x | 1.61x | 1.38x | 1.2x | 0.73x | 0.62x | 0.52x |
| EV / EBITDA | 9.58x | 6.25x | 6.23x | 6.09x | 3.52x | 2.95x | 2.4x |
| EV / EBIT | 14.8x | 11.3x | 12.4x | 12.1x | 6.16x | 4.85x | 3.75x |
| EV / FCF | -41.5x | -67.9x | 11.4x | -7.31x | 6.16x | 4.85x | 3.75x |
| FCF Yield | -2.41% | -1.47% | 8.74% | -13.7% | 16.2% | 20.6% | 26.7% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | - | - | - | - | 0.13 | 0.11 | 0.14 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 5.028 | 6.264 | 6.339 | 10.03 | 10.1 | 11 | 11.6 |
| EBITDA 1 | 1.804 | 1.611 | 1.401 | 1.977 | 2.1 | 2.3 | 2.5 |
| EBIT 1 | 1.17 | 0.8922 | 0.7048 | 0.9924 | 1.2 | 1.4 | 1.6 |
| Net income 1 | 0.7161 | 0.5903 | 0.3528 | 0.737 | 0.8 | 0.6 | 0.8 |
| Net Debt 1 | -0.9976 | -1.725 | -2.073 | -0.4974 | -1.8 | -2.4 | -3.2 |
| Reference price 2 | 2.030 | 1.310 | 1.265 | 1.470 | 1.080 | 1.080 | 1.080 |
| Nbr of stocks (in thousands) | 9,000 | 9,000 | 8,537 | 8,524 | 8,513 | - | - |
| Announcement Date | 31/03/23 | 08/05/24 | 31/03/25 | 12/04/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 8.31x | 0.73x | 3.52x | - | 10.25M | |
| 39.62x | 13.42x | 28.51x | 0.5% | 1,206B | |
| 40.43x | 6.79x | 19.09x | 1.93% | 665B | |
| 37.45x | 8.51x | 17.57x | 2.38% | 515B | |
| 20.98x | 5.12x | 12.74x | 2.57% | 381B | |
| 97.18x | 5.95x | 25.33x | 2.32% | 362B | |
| 23.18x | 5.95x | 14.36x | 2.69% | 307B | |
| 24.46x | 4.89x | 13.77x | 1.79% | 289B | |
| 23.66x | 7.32x | 13.53x | 2.19% | 249B | |
| -39.95x | 7.29x | 45.82x | 1.98% | 207B | |
| Average | 27.53x | 6.60x | 19.42x | 2.04% | 417.98B | |
| Weighted average by Cap. | 35.62x | 8.55x | 21.86x | 1.73% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ERFO Stock
- Valuation Laboratorio Farmaceutico Erfo S.p.A.
Select your edition
All financial news and data tailored to specific country editions
